Cat. No. | Product name | CAS No. |
DC9765 |
CERC-501(LY-2456302,Aticaprant)
Featured
CERC-501(LY-2456302) is a potent, selective antagonist of the kappa opioid receptor (KOR) (Ki = 0.81 nM vs. 24.0 nM and 155 nM for the μ-opioid receptor (MOR) and δ-opioid receptor (DOR), respectively. |
1174130-61-0 |
DCAPI1569 |
Cilostazol
Cilastazol is a 2-oxo-quinoline with vasodilator, antimitogenic, antithrombotic, and cardiotonic properties. This compound has been shown to cause inhibition of adenosine uptake, eventually resulting in changes to cAMP levels. Studies have shown Cilostazo |
73963-72-1 |
DC11673 |
CK-2127107
Featured
CK-2127107(CK-107, Reldesemtiv) is a novel orally active fast skeletal troponin activator, selectively activates fast skeletal myofibrils with EC50 of 3.4 uM. |
1345410-31-2 |
DC9067 |
Clozapine
Clozapine(HF 1854) is a 5-HT2A/2C and dopamine receptor blocker with Ki values of 21, 170, 170, 230 and 330 nM for D4, D3, D1, D2 and D5 receptors respectively. |
5786-21-0 |
DC8095 |
Raxatrigine hydrochloride
Featured
CNV1014802(GSK-1014802) is a novel small molecule state-dependent sodium channel blocker; Nav1.7 sodium channel inhibitor. |
934240-31-0 |
DC10506 |
CPHPC(Miridesap)
Featured
CPHPC(GSK2315698,Miridesap) is a divalent crosslinker of SAP that causes rapid depletion of circulating SAP via hepatic clearance. |
224624-80-0 |
DC7391 |
CVT-10216
Featured
CVT-10216 is a potent and selective, reversible inhibitor of aldehyde dehydrogenase 2 (ALDH2) (IC50 values are 29 and 1300 nM for ALDH2 and ALDH1, respectively). |
1005334-57-5 |
DC9551 |
Difluprednate
Featured
Difluprednate(Durezol) is a corticosteroid, approved difluprednate for the treatment of post-operative ocular inflammation and pain. |
23674-86-4 |
DC11103 |
Tavapadon
Featured
Tavapadon is a potent, orally-bioavailable, selective partial agonist of the dopamine D1 and D5 receptors. |
1643489-24-0 |
DC8277 |
E-2012
Featured
E 2012 is a potent γ-secretase modulator. |
870843-42-8 |
DC11551 |
Elenbecestat
Featured
Elenbecestat (E2609) is a novel potent, oral BACE1 inhibitor for treatment of Alzheimer's disease.. |
1388149-39-0 |
DC8323 |
Eletriptan HBr
Featured
Eletriptan HBr is an orally active, selective 5-HT1B/1D receptor agonist. |
177834-92-3 |
DC8268 |
Eliprodil
Featured
Eliprodil is a non-competitive NMDA receptor antagonist that acts at the polyamine modulatory site. |
119431-25-3 |
DC10869 |
Olodanrigan(EMA401)
Featured
EMA401(Olodanrigan) is a highly selective AT2R antagonist, inhibition of augmented AngII/AT2R induced p38 and p42/p44 MAPK activation, and hence inhibition of DRG neuron hyperexcitability and sprouting of DRG neurons. |
1316755-16-4 |
DC11028 |
EMD-281014 hydrochloride
EMD-281014 hydrochloride is a potent, highly selective 5-HT2A antagonist with Ki of 0.87 nM, displays little to no affinity for 5-HT2C receptors (Ki=557 nM), human D2 receptors and IKr channels. |
443144-27-2 |
DC11027 |
EMD-281014
EMD-281014 is a potent, highly selective 5-HT2A antagonist with Ki of 0.87 nM, displays little to no affinity for 5-HT2C receptors (Ki=557 nM), human D2 receptors and IKr channels. |
443144-26-1 |
DC9260 |
Eptapirone
Featured
Eptapirone (F-11,440) is a very potent and highly selective 5-HT1A receptor full agonist of the azapirone family. |
179756-58-2 |
DCAPI1535 |
Etodolac
Etodolac is a Cox-2 inhibitor with anti-inflammatory and analgesic activity. Etodolac is shown to inhibit growth and PCNA expression and induce cell cycle arrest in human hepatocellular carcinoma cell lines, in addition to suppressing the occurrence of ab |
41340-25-4 |
DC4239 |
Flupirtine maleate
Flupirtine maleateis a non-opioid, centrally acting analgesia, muscle relaxation and neuroprotection. Currently under a clinical trial (recruiting phase) as a treatment for Multiple Sclerosis and has been used as an analgesic. |
75507-68-5 |
DCAPI1206 |
Flurbiprofen (Ansaid)
Flurbiprofen (Ansaid) |
5104-49-4 |
DC7014 |
GPI-1046
For the detailed information of GPI-1046, the solubility of GPI-1046 in water, the solubility of GPI-1046 in DMSO, the solubility of GPI-1046 in PBS buffer, the animal experiment (test) of GPI-1046, the cell expriment (test) of GPI-1046, the in vivo, in vitro and clinical trial test of GPI-1046, the EC50, IC50,and Affinity of GPI-1046, Please contact DC Chemicals.. |
186452-09-5 |
DC7016 |
JNJ40411813
For the detailed information of JNJ40411813, the solubility of JNJ40411813 in water, the solubility of JNJ40411813 in DMSO, the solubility of JNJ40411813 in PBS buffer, the animal experiment (test) of JNJ40411813, the cell expriment (test) of JNJ40411813, the in vivo, in vitro and clinical trial test of JNJ40411813, the EC50, IC50,and Affinity of JNJ40411813, Please contact DC Chemicals.. |
1127498-03-6 |